SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why?
PRCT 31.91+1.9%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Matthew Bender who wrote (181)7/8/1997 8:38:00 AM
From: Douglas   of 455
 
WHO'S NEWS: PROCEPT INC. (THE WALL STREET JOURNAL-JULY 8, 1997)

PROCEPT Inc. (Cambridge, Mass.)--This biotechnology company named Michael S. Weiss, 31 years old, interim chairman, a new position for the company. Mr. Weiss, a senior managing director of Paramount Capital Inc., a New York investment-banking firm, will become permanent chairman if the decision is approved at the next shareholder meeting, Procept said. He also was elected to the board, increasing the number of directors to five. His appointment as interim chairman coincides with a $3 million investment in Procept by Paramount's Aires Fund and Aries Domestic Fund L.P. The two funds now own about 25% of the company and could, if all warrants are exercised, own slighly more than half the company within five years, said Stanley C. Erck, Procept's chief executive officer.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext